Literature DB >> 27567691

Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic Steatohepatitis in Adults and Children.

Rotonya M Carr1, Ravindra Dhir2, Kalyankar Mahadev3, Megan Comerford4, Naga P Chalasani4, Rexford S Ahima5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27567691      PMCID： PMC5161563          DOI： 10.1016/j.cgh.2016.08.023

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  8 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

2.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

3.  Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein.

Authors:  Benny Hung-Junn Chang; Lan Li; Antoni Paul; Susumu Taniguchi; Vijayalakshmi Nannegari; William C Heird; Lawrence Chan
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Inhibition of ADRP prevents diet-induced insulin resistance.

Authors:  Gladys M Varela; Daniel A Antwi; Ravindra Dhir; Xiaoyan Yin; Neel S Singhal; Mark J Graham; Roseanne M Crooke; Rexford S Ahima
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-31       Impact factor: 4.052

Review 5.  Advances in pediatric nonalcoholic fatty liver disease.

Authors:  Rohit Loomba; Claude B Sirlin; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

6.  Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease.

Authors:  James L McManaman; Elise S Bales; David J Orlicky; Matthew Jackman; Paul S MacLean; Shannon Cain; Amanda E Crunk; Ayla Mansur; Christine E Graham; Thomas A Bowman; Andrew S Greenberg
Journal:  J Lipid Res       Date:  2013-02-12       Impact factor: 5.922

7.  Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis.

Authors:  Beate Katharina Straub; Pamela Stoeffel; Hans Heid; Ralf Zimbelmann; Peter Schirmacher
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

8.  Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice.

Authors:  Rotonya M Carr; Giselle Peralta; Xiaoyan Yin; Rexford S Ahima
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240
  8 in total
  8 in total

Review 1.  Alcohol effects on hepatic lipid metabolism.

Authors:  Sookyoung Jeon; Rotonya Carr
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

2.  Perilipins at a glance.

Authors:  Charles P Najt; Mahima Devarajan; Douglas G Mashek
Journal:  J Cell Sci       Date:  2022-03-09       Impact factor: 5.235

3.  A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.

Authors:  Bianca Williams; Jason Correnti; Amanke Oranu; Annie Lin; Victoria Scott; Maxine Annoh; James Beck; Emma Furth; Victoria Mitchell; Can E Senkal; Lina Obeid; Rotonya M Carr
Journal:  FASEB J       Date:  2017-09-01       Impact factor: 5.191

4.  Rapid Lipid Droplet Isolation Protocol Using a Well-established Organelle Isolation Kit.

Authors:  Jascha Brettschneider; Jason M Correnti; Chelsea Lin; Bianca Williams; Amanke Oranu; Amy Kuriakose; Dru McIver-Jenkins; Abigail Haba; Isabelle Kaneza; Sookyoung Jeon; Eleonora Scorletti; Rotonya M Carr
Journal:  J Vis Exp       Date:  2019-04-19       Impact factor: 1.355

Review 5.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

6.  Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway.

Authors:  Olfa Khalifa; Neyla S Al-Akl; Khaoula Errafii; Abdelilah Arredouani
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.996

7.  Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway.

Authors:  Jinmi Lee; Seok-Woo Hong; Min-Jeong Kim; Sun Joon Moon; Hyemi Kwon; Se Eun Park; Eun-Jung Rhee; Won-Young Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-09

Review 8.  Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.

Authors:  Douglas G Mashek
Journal:  Mol Metab       Date:  2020-11-10       Impact factor: 7.422
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.